Reference
Peverelle M, et al. Real-world outcomes of vedolizumab for inflammatory bowel disease post liver transplantation. Journal of Crohn's and Colitis 12 (Suppl. 1): S356-S357 abstr. P496, Feb 2018 [abstract] - Australia
Rights and permissions
About this article
Cite this article
Vedolizumab. Reactions Weekly 1697, 382 (2018). https://doi.org/10.1007/s40278-018-44938-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-44938-9